California-based Dr. Bronner’s, family-owned maker of a natural brand of soap in North America, has launched its Heal Soul campaign to support public education efforts, advocacy organizations, and political campaigns around the country working to mainstream psychedelic-assisted therapy and medicines to treat depression, PTSD, addiction and end-of-life anxiety. The company has donated over $3 million this year to support these efforts and created a special limited edition “Heal Soul!” label on its 32-oz. Castile Liquid Soaps now available nationwide. The label aims to educate the public about these life-saving therapies and medicines, and the advocacy organizations and ballot initiatives that are advancing this work. To read the “Heal Soul!” label in its entirety, visit: https://bit.ly/2EUnoxb.

“Our world is grappling with epidemics of depression, anxiety, PTSD, and addiction that modern pharmaceutical approaches often fail to adequately address. Psychedelic-assisted therapy is life-saving medicine that the world needs now, especially highly traumatized populations like veterans, first responders and marginalized communities generally,” said David Bronner, cosmic engagement officer (CEO) of Dr. Bronner’s. “Our family is no stranger to severe depression and anxiety, and I’ve personally experienced the deep healing that these medicines can provide."

According to the company, psychedelic-assisted therapy has shown great promise in clinical trials at John Hopkins, NYU, UCLA and elsewhere for treating severe psychological disorders. In 2017 and 2018, the U.S. Food and Drug Administration (FDA) granted “breakthrough status” for MDMA (methylenedioxymethamphetamine)-assisted therapy for treatment-resistant PTSD, and psilocybin-assisted therapy for treatment-resistant depression, respectively. Breakthrough status means that the FDA considers that these therapies may demonstrate substantial improvement over other available options and prioritizes review of safety and efficacy studies in clinical trials accordingly. Canada recently approved psilocybin-therapy for people who are terminally ill and grappling with severe end-of-life anxiety.

“Used in the right settings, in combination with good diet, fitness, and other healthy lifestyle choices, psychedelic-assisted therapies and medicines offer dramatic healing for many people suffering from depression, end-of-life anxiety, PTSD, and other mental health conditions,” said Michael Bronner, president of Dr. Bronner’s. “Our Heal Soul message and campaign is about mainstreaming this conversation in a rational and compassionate way, to help enable access to these life-saving therapies as soon as possible with the goal of evaporating the misguided stigma that these medicines face.”

For more information, visit https://www.drbronner.com/.